Malak Sabbah
Overview
Explore the profile of Malak Sabbah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krayem M, Aftimos P, Najem A, van den Hooven T, van den Berg A, Hovestad-Bijl L, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061253
In the original article [...].
2.
Hjazeen A, Kannan S, Al-Maqableh H, Maitah S, Abu-Radwan M, Sabbah M
Cureus
. 2024 May;
16(4):e58228.
PMID: 38745802
Psychological empowerment is a motivational concept that encompasses a person's thoughts and perceptions that give a sense of behavior and commitment to the work. Psychological empowerment is widely acknowledged to...
3.
Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136445
In the original article [...].
4.
Sabbah M, Najem A, Vanderkerkhove C, Kert F, Jourani Y, Journe F, et al.
Front Med (Lausanne)
. 2023 May;
10:1149918.
PMID: 37215708
Melanoma is known to be a radioresistant cancer. Melanoma radioresistance can be due to several factors such as pigmentation, antioxidant defenses and high Deoxyribonucleic acid (DNA) repair efficacy. However, irradiation...
5.
Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, et al.
Cells
. 2022 Apr;
11(7).
PMID: 35406721
Melanoma cells are notorious for their high plasticity and ability to switch back and forth between various melanoma cell states, enabling the adaptation to sub-optimal conditions and therapeutics. This phenotypic...
6.
Najem A, Wouters J, Krayem M, Rambow F, Sabbah M, Sales F, et al.
Front Oncol
. 2021 Dec;
11:780654.
PMID: 34869032
The use of patient-derived primary cell cultures in cancer preclinical assays, including drug screens and genotoxic studies, has increased in recent years. However, their translational value is constrained by several...
7.
Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33918490
MAPK (mitogen activated protein kinase) and PI3K/AKT (Phosphatidylinositol-3-Kinase and Protein Kinase B) pathways play a key role in melanoma progression and metastasis that are regulated by receptor tyrosine kinases (RTKs)....
8.
Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, et al.
Mol Cancer Res
. 2021 Mar;
19(7):1221-1233.
PMID: 33741716
Amplification or activating mutations of c-Kit are a frequent oncogenic alteration, which occurs commonly in acral and mucosal melanoma. Among c-Kit inhibitors, dasatinib is the most active due to its...
9.
Krayem M, Aftimos P, Najem A, van den Hooven T, van den Berg A, Hovestad-Bijl L, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33066704
The authors would like to make a correction to their published paper [...].
10.
Tetu P, Delyon J, Andre J, Reger De Moura C, Sabbah M, Ghanem G, et al.
Cancers (Basel)
. 2020 Apr;
12(5).
PMID: 32344828
KIT is a bona fide oncogene in a subset of melanoma and, ex vivo, KIT inhibitors are very efficient at killing KIT-mutant melanoma cell lines. However, KIT-mutant melanoma tumors tend...